Coronary atherosclerotic heart disease
Conditions
Interventions
CHD-PBSS:None
CHD-NPBSS:None
Sponsors
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients who met the diagnostic criteria for both CHD and PBSS were included in the CHD-PBSS group, while those who met the diagnostic criteria for CHD but not PBSS were included in the CHD-NPBSS group. (2) The age range of patients included in both groups is 35 to 70 years. (3) Patients who volunteered for the study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with unstable angina, acute myocardial infarction; (2) Patients with chest pain due to other congenital diseases of the heart, valvular disease, and severe neurosis; (3) Patients with acute stage of cerebral infarction; (4) Patients with severe primary diseases such as combined liver, kidney and hematopoietic system; (5) Patients with combination of other more serious diseases that must be treated (e.g., blood diseases, tumors, etc.); (6) Patients with acute infection within the last 2 weeks; (7) Pregnant or lactating women; (8) Other conditions deemed unsuitable by the study physician for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood lipid biomakers;Coagulation biomakers; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory biomakers; | — |
Countries
China
Contacts
Public ContactTong Xu
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences
Outcome results
None listed